Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

colorectal cancer

  • Open Access
    MDM1 overexpression promotes p53 expression and cell apoptosis to enhance therapeutic sensitivity to chemoradiotherapy in patients with colorectal cancer
    Ningxin Ren, Hongxia Chen, Ying Huang, Jing Jin, Shaosen Zhang, Ruoqing Yan, Mengjie Li, Linlin Zheng, Shuangmei Zou, Yexiong Li, Wen Tan and Dongxin Lin
    Cancer Biology & Medicine March 2025, 22 (3) 266-283; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0540
  • Open Access
    Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling
    Wenhua Li, Huan Zhang, Zhe Gong, Yue Li, Zhiyu Chen, Xiaodong Zhu, Mingzhu Huang, Zhe Zhang, Chenchen Wang, Lixin Qiu, Qirong Geng, Jinjia Chang, Xiaoying Zhao, Xuedan Sheng, Wen Zhang, Tong Tong and Weijian Guo
    Cancer Biology & Medicine February 2025, 22 (2) 166-176; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0389
  • Open Access
    Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans
    Bhaskar Roy, Kunfeng Cao, Chabungbam Orville Singh, Xiaodong Fang, Huanming Yang and Dong Wei
    Cancer Biology & Medicine February 2025, 22 (2) 93-112; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0263
  • Open Access
    Amplifying colorectal cancer progression: impact of a PDIA4/SP1 positive feedback loop by circPDIA4 sponging miR-9-5p
    Yan Zhuang, Yiding Ai, Peng Li, Xin Yue, Yue Li, Luling Shan, Tongtong Wang, Peng Zhao and Xun Jin
    Cancer Biology & Medicine October 2024, 21 (10) 916-933; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0112
  • Open Access
    The current role of dendritic cells in the progression and treatment of colorectal cancer
    Yuanci Zhang, Songtao Ji, Ge Miao, Shuya Du, Haojia Wang, Xiaohua Yang, Ang Li, Yuanyuan Lu, Xin Wang and Xiaodi Zhao
    Cancer Biology & Medicine September 2024, 21 (9) 769-783; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0188
  • Open Access
    Effectiveness of colorectal cancer screening integrating non-genetic and genetic risk: a prospective study based on UK Biobank data
    Yu Zhang, Chao Sheng, Zhangyan Lyu, Hongji Dai, Fangfang Song, Fengju Song, Yubei Huang and Kexin Chen
    Cancer Biology & Medicine August 2024, 21 (8) 712-723; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0096
  • Open Access
    Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
    Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba
    Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301
  • Open Access
    The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer
    Sen Wang, Benling Xu, Yangyang Zhang, Guangyu Chen, Peng Zhao, Quanli Gao and Long Yuan
    Cancer Biology & Medicine January 2024, 21 (1) 65-82; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0376
  • You have access
    The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
    Xiaohui Wang, Wei Qiu, Haoyu Liu, Min He, Wei He, Zhan Li, Zhiqiang Wu, Xiang Xu and Ping Chen
    Cancer Biology & Medicine September 2023, 20 (9) 662-681; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0033
  • You have access
    Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers
    Juan Hui, Mingzhen Zhou, Guangzhou An, Hui Zhang, Yuanyuan Lu, Xin Wang and Xiaodi Zhao
    Cancer Biology & Medicine August 2023, 20 (8) 575-598; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0119

Pages

  • Next
  • 1
  • 2
  • 3
  • 4

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire